Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study

Abstract Background Hepatoid adenocarcinoma of the stomach (HAS) is a highly malignant and rare extrahepatic tumor. The prognosis is controversial because of its rarity and the lack of multi-center cohort studies, especially on the influence of serum Alpha-fetoprotein (AFP) level on prognosis. We ai...

Full description

Bibliographic Details
Main Authors: Lamei Li, Xinle Yang, Wei Ji, Qi Zhu, Xin Yang, Junqi Niu, Wanyu Li
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-023-02773-9
_version_ 1797827528270807040
author Lamei Li
Xinle Yang
Wei Ji
Qi Zhu
Xin Yang
Junqi Niu
Wanyu Li
author_facet Lamei Li
Xinle Yang
Wei Ji
Qi Zhu
Xin Yang
Junqi Niu
Wanyu Li
author_sort Lamei Li
collection DOAJ
description Abstract Background Hepatoid adenocarcinoma of the stomach (HAS) is a highly malignant and rare extrahepatic tumor. The prognosis is controversial because of its rarity and the lack of multi-center cohort studies, especially on the influence of serum Alpha-fetoprotein (AFP) level on prognosis. We aimed to analyze the clinicopathological characteristics and prognosis of HAS, particularly the effect of serum AFP on the prognosis of HAS. Methods We retrospectively reviewed clinical data of one HAS patient treated at our institution in 2019 and of 252 patients reported between 1984 and 2020 in research databases. Results Among these patients, 60.1% were > 60 years, 51% had lesions in the gastric antrum, and 51.0% (73/143) had the ulcerative lesion type. The preoperative elevated levels of serum alpha-fetoprotein (AFP) were detected in most patients (76.7%). Lymph-node (84.6%) and preoperative liver metastasis (39.1%) were often found. The high-AFP group was characterized by a higher rate of stage IV (P = 0.000682) and liver metastasis (P = 0.000068). The 1-, 3-and 5-year progression-free survival(PFS) rates were 41%, 18%, and 0%, and the 1-, 3-, and 5-year overall survival (OS) rates were 64%, 26%, and 21%, respectively. The survival analysis showed that OS was significantly shorter for HAS with high-AFP (> 300 ng/ml) than with low-AFP (≤ 300 ng/ml) (P = 0.023). The univariate analysis indicated that the OS of HAS was associated with tumor location, pTNM stage, lymph-node metastasis, surgical resection, and serum AFP > 300 ng/ml. However,the prognostic factors for PFS was only pTNM stage and surgical resection. The multivariate analysis confirmed that the independent prognostic factor affecting OS of HAS included pTNM stage and surgical resection. Conclusions Liver metastasis was increasingly more likely with increasingly higher serum AFP, but the prognosis of HAS is not necessarily poor. Serum AFP level is an important prognostic indicator in HAS and should be monitored.
first_indexed 2024-04-09T12:49:46Z
format Article
id doaj.art-b12eb45d7c5e40f0ac3c42c3412b1430
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-04-09T12:49:46Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-b12eb45d7c5e40f0ac3c42c3412b14302023-05-14T11:18:46ZengBMCBMC Gastroenterology1471-230X2023-05-012311810.1186/s12876-023-02773-9Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective studyLamei Li0Xinle Yang1Wei Ji2Qi Zhu3Xin Yang4Junqi Niu5Wanyu Li6Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Hepatology, First Hospital, Jilin UniversityDepartment of Oncology, First Hospital, Jilin UniversityDepartment of Hepatology, First Hospital, Jilin UniversityDepartment of Hepatology, First Hospital, Jilin UniversityDepartment of Hepatology, First Hospital, Jilin UniversityDepartment of Hepatology, First Hospital, Jilin UniversityAbstract Background Hepatoid adenocarcinoma of the stomach (HAS) is a highly malignant and rare extrahepatic tumor. The prognosis is controversial because of its rarity and the lack of multi-center cohort studies, especially on the influence of serum Alpha-fetoprotein (AFP) level on prognosis. We aimed to analyze the clinicopathological characteristics and prognosis of HAS, particularly the effect of serum AFP on the prognosis of HAS. Methods We retrospectively reviewed clinical data of one HAS patient treated at our institution in 2019 and of 252 patients reported between 1984 and 2020 in research databases. Results Among these patients, 60.1% were > 60 years, 51% had lesions in the gastric antrum, and 51.0% (73/143) had the ulcerative lesion type. The preoperative elevated levels of serum alpha-fetoprotein (AFP) were detected in most patients (76.7%). Lymph-node (84.6%) and preoperative liver metastasis (39.1%) were often found. The high-AFP group was characterized by a higher rate of stage IV (P = 0.000682) and liver metastasis (P = 0.000068). The 1-, 3-and 5-year progression-free survival(PFS) rates were 41%, 18%, and 0%, and the 1-, 3-, and 5-year overall survival (OS) rates were 64%, 26%, and 21%, respectively. The survival analysis showed that OS was significantly shorter for HAS with high-AFP (> 300 ng/ml) than with low-AFP (≤ 300 ng/ml) (P = 0.023). The univariate analysis indicated that the OS of HAS was associated with tumor location, pTNM stage, lymph-node metastasis, surgical resection, and serum AFP > 300 ng/ml. However,the prognostic factors for PFS was only pTNM stage and surgical resection. The multivariate analysis confirmed that the independent prognostic factor affecting OS of HAS included pTNM stage and surgical resection. Conclusions Liver metastasis was increasingly more likely with increasingly higher serum AFP, but the prognosis of HAS is not necessarily poor. Serum AFP level is an important prognostic indicator in HAS and should be monitored.https://doi.org/10.1186/s12876-023-02773-9Hepatoid adenocarcinoma of  stomachClinicopathological characteristicsPrognosisAFP level
spellingShingle Lamei Li
Xinle Yang
Wei Ji
Qi Zhu
Xin Yang
Junqi Niu
Wanyu Li
Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study
BMC Gastroenterology
Hepatoid adenocarcinoma of  stomach
Clinicopathological characteristics
Prognosis
AFP level
title Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study
title_full Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study
title_fullStr Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study
title_full_unstemmed Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study
title_short Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study
title_sort emphasis on the clinical relationship between alpha fetoprotein and hepatoid adenocarcinoma of the stomach a retrospective study
topic Hepatoid adenocarcinoma of  stomach
Clinicopathological characteristics
Prognosis
AFP level
url https://doi.org/10.1186/s12876-023-02773-9
work_keys_str_mv AT lameili emphasisontheclinicalrelationshipbetweenalphafetoproteinandhepatoidadenocarcinomaofthestomacharetrospectivestudy
AT xinleyang emphasisontheclinicalrelationshipbetweenalphafetoproteinandhepatoidadenocarcinomaofthestomacharetrospectivestudy
AT weiji emphasisontheclinicalrelationshipbetweenalphafetoproteinandhepatoidadenocarcinomaofthestomacharetrospectivestudy
AT qizhu emphasisontheclinicalrelationshipbetweenalphafetoproteinandhepatoidadenocarcinomaofthestomacharetrospectivestudy
AT xinyang emphasisontheclinicalrelationshipbetweenalphafetoproteinandhepatoidadenocarcinomaofthestomacharetrospectivestudy
AT junqiniu emphasisontheclinicalrelationshipbetweenalphafetoproteinandhepatoidadenocarcinomaofthestomacharetrospectivestudy
AT wanyuli emphasisontheclinicalrelationshipbetweenalphafetoproteinandhepatoidadenocarcinomaofthestomacharetrospectivestudy